{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:29:43Z","timestamp":1790141383084,"version":"4.0.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T00:00:00Z","timestamp":1704153600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T00:00:00Z","timestamp":1704153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The\u00a0therapeutic efficacy of\u00a0renin-angiotensin system inhibitors\u00a0(RASi) in elderly\u00a0patients with hypertension and at risk of fractures\u00a0has been in the limelight because\u00a0of accumulating evidence that localized RAS activation in bone tissue leads to osteoclastic bone resorption, resulting in osteoporosis. This study set out to investigate the association between RASi use and fracture incidence in a large cohort.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We employed a nested case\u2013control design to investigate the association between RASi use and newly developed fractures. A case was defined as a patient newly diagnosed with a fracture between January 2004 and December 2015. We selected 1,049 cases and controls using 1:1 propensity score matching.\u00a0Conditional logistic regression analysis was conducted to estimate the association between RASi exposure and fracture incidence.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Overall, RASi usage was significantly associated with lower odds for fracture incidence (ever-users vs never-users: OR, 0.73; 95% CI, 0.59\u20130.91). We found that ARB-only users experienced\u00a0fewer\u00a0fractures than RASi-never users (OR, 0.65; 95% CI, 0.49\u20130.86),\u00a0whereas ACEi-only users\u00a0or ARB\/ACEi-ever users did not. In subgroup analysis, RASi-ever users without cerebrovascular disease, those with a BMI exceeding 23, and statin exposure had significantly lower ORs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The present study\u00a0established a significant association between RASi use and reduced fracture incidence,\u00a0thus highlighting\u00a0the potential clinical utility of RASi use as a preventive strategy in elderly patients at risk for osteoporotic fractures.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12891-023-07102-5","type":"journal-article","created":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T09:02:23Z","timestamp":1704186143000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["The impact of Renin-Angiotensin System Inhibitors on bone fracture risk: a nationwide nested case-control study"],"prefix":"10.1186","volume":"25","author":[{"given":"Kwang Min","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Jung","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangjin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong-Hyun","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,2]]},"reference":[{"key":"7102_CR1","doi-asserted-by":"publisher","first-page":"S243","DOI":"10.1093\/geront\/gnw002","volume":"56 Suppl 2","author":"AM Briggs","year":"2016","unstructured":"Briggs AM, Cross MJ, Hoy DG, Sanchez-Riera L, Blyth FM, Woolf AD, et al. Musculoskeletal Health conditions represent a global threat to healthy aging: a report for the 2015 World Health Organization World Report on ageing and health. Gerontologist. 2016;56 Suppl 2:S243-255.","journal-title":"Gerontologist"},{"key":"7102_CR2","doi-asserted-by":"publisher","first-page":"171","DOI":"10.5312\/wjo.v7.i3.171","volume":"7","author":"P Pisani","year":"2016","unstructured":"Pisani P, Renna MD, Conversano F, Casciaro E, Di Paola M, Quarta E, et al. Major osteoporotic fragility fractures: risk factor updates and societal impact. World J Orthop. 2016;7:171\u201381.","journal-title":"World J Orthop"},{"key":"7102_CR3","first-page":"65","volume":"7","author":"T Willson","year":"2015","unstructured":"Willson T, Nelson SD, Newbold J, Nelson RE, LaFleur J. The clinical epidemiology of male osteoporosis: a review of the recent literature. Clin Epidemiol. 2015;7:65\u201376.","journal-title":"Clin Epidemiol"},{"key":"7102_CR4","doi-asserted-by":"publisher","first-page":"137","DOI":"10.4149\/endo_2013_03_137","volume":"47","author":"A Polymeris","year":"2013","unstructured":"Polymeris A, Michalakis K, Sarantopoulou V. Secondary osteoporosis - an endocrinological approach focusing on underlying mechanisms. Endocr Regul. 2013;47:137\u201348.","journal-title":"Endocr Regul"},{"key":"7102_CR5","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/S0140-6736(18)32112-3","volume":"393","author":"JE Compston","year":"2019","unstructured":"Compston JE, McClung MR, Leslie WD. Osteoporosis. Lancet. 2019;393:364\u201376.","journal-title":"Lancet"},{"key":"7102_CR6","first-page":"816","volume":"52","author":"J Wang","year":"2018","unstructured":"Wang J, Li HL, Ma X, Han LH, Fang J, Gao LF, et al. [A nested case-control study of cruciferous vegetables intake, urinary isothiocyanates level and Lung cancer risk among men in urban Shanghai]. Zhonghua Yu Fang Yi Xue Za Zhi. 2018;52:816\u201321.","journal-title":"Zhonghua Yu Fang Yi Xue Za Zhi"},{"key":"7102_CR7","doi-asserted-by":"publisher","first-page":"161S","DOI":"10.1093\/ajh\/3.8.161","volume":"3","author":"EW Young","year":"1990","unstructured":"Young EW, McCarron DA, Morris CD. Calcium regulating hormones in essential hypertension. Importance of gender. Am J Hypertens. 1990;3:161S-166S.","journal-title":"Am J Hypertens"},{"key":"7102_CR8","doi-asserted-by":"publisher","first-page":"932691","DOI":"10.1155\/2013\/932691","volume":"2013","author":"Y Gebru","year":"2013","unstructured":"Gebru Y, Diao TY, Pan H, Mukwaya E, Zhang Y. Potential of RAS inhibition to improve metabolic bone disorders. Biomed Res Int. 2013;2013:932691.","journal-title":"Biomed Res Int"},{"key":"7102_CR9","first-page":"e15","volume":"46","author":"J Lee","year":"2017","unstructured":"Lee J, Lee JS, Park SH, Shin SA, Kim K. Cohort Profile: the National Health Insurance Service-National Sample Cohort (NHIS-NSC), South Korea. Int J Epidemiol. 2017;46:e15.","journal-title":"Int J Epidemiol"},{"key":"7102_CR10","doi-asserted-by":"publisher","first-page":"11748","DOI":"10.1038\/s41598-018-29629-7","volume":"8","author":"SY Kim","year":"2018","unstructured":"Kim SY, Kim HJ, Lim H, Kong IG, Kim M, Choi HG. Bidirectional association between gastroesophageal reflux disease and depression: two different nested case-control studies using a national sample cohort. Sci Rep. 2018;8:11748.","journal-title":"Sci Rep"},{"key":"7102_CR11","doi-asserted-by":"publisher","first-page":"e016640","DOI":"10.1136\/bmjopen-2017-016640","volume":"7","author":"SC Seong","year":"2017","unstructured":"Seong SC, Kim YY, Park SK, Khang YH, Kim HC, Park JH, et al. Cohort profile: the National Health Insurance Service-National Health Screening Cohort (NHIS-HEALS) in Korea. BMJ Open. 2017;7:e016640.","journal-title":"BMJ Open"},{"key":"7102_CR12","volume-title":"Guidelines for ATC classification and DDD assignment. WHO collaborating centre for drug statistic methodology edn","author":"WHO Collaborating Centre for Drug Statistic Methodology","year":"2003","unstructured":"WHO Collaborating Centre for Drug Statistic Methodology. Guidelines for ATC classification and DDD assignment. WHO collaborating centre for drug statistic methodology edn. Oslo: WHO; 2003."},{"key":"7102_CR13","first-page":"370","volume":"17","author":"WH Pan","year":"2008","unstructured":"Pan WH, Yeh WT. How to define obesity? Evidence-based multiple action points for public awareness, screening, and treatment: an extension of asian-pacific recommendations. Asia Pac J Clin Nutr. 2008;17:370\u20134.","journal-title":"Asia Pac J Clin Nutr"},{"key":"7102_CR14","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/j.jclinepi.2008.01.006","volume":"61","author":"ME Charlson","year":"2008","unstructured":"Charlson ME, Charlson RE, Peterson JC, Marinopoulos SS, Briggs WM, Hollenberg JP. The Charlson comorbidity index is adapted to predict costs of chronic disease in primary care patients. J Clin Epidemiol. 2008;61:1234\u201340.","journal-title":"J Clin Epidemiol"},{"key":"7102_CR15","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1093\/aje\/kwq224","volume":"172","author":"PC Austin","year":"2010","unstructured":"Austin PC. Statistical criteria for selecting the optimal number of untreated subjects matched to each treated subject when using many-to-one matching on the propensity score. Am J Epidemiol. 2010;172:1092\u20137.","journal-title":"Am J Epidemiol"},{"key":"7102_CR16","unstructured":"Shaker JL, Deftos L. Calcium and Phosphate Homeostasis. In: Feingold KR, Anawalt B, Boyce A, Chrousos G, de Herder WW, Dungan K, et al. editors. Endotext. South Dartmouth: 2000."},{"key":"7102_CR17","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1111\/j.1440-1681.1991.tb01637.x","volume":"18","author":"M Imaoka","year":"1991","unstructured":"Imaoka M, Morimoto S, Kitano S, Fukuo F, Ogihara T. Calcium metabolism in elderly hypertensive patients: possible participation of exaggerated sodium, calcium and phosphate excretion. Clin Exp Pharmacol Physiol. 1991;18:631\u201341.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"7102_CR18","doi-asserted-by":"publisher","first-page":"e016992","DOI":"10.1136\/bmjopen-2017-016992","volume":"7","author":"SM Lin","year":"2017","unstructured":"Lin SM, Yang SH, Cheng HY, Liang CC, Huang HK. Thiazide diuretics and the risk of hip fracture after stroke: a population-based propensity-matched cohort study using Taiwan\u2019s National Health Insurance Research Database. BMJ Open. 2017;7:e016992.","journal-title":"BMJ Open"},{"key":"7102_CR19","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1001\/jama.292.11.1326","volume":"292","author":"RG Schlienger","year":"2004","unstructured":"Schlienger RG, Kraenzlin ME, Jick SS, Meier CR. Use of beta-blockers and risk of fractures. JAMA. 2004;292:1326\u201332.","journal-title":"JAMA"},{"key":"7102_CR20","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.bone.2005.09.011","volume":"38","author":"H Lynn","year":"2006","unstructured":"Lynn H, Kwok T, Wong SY, Woo J, Leung PC. Angiotensin converting enzyme inhibitor use is associated with higher bone mineral density in elderly Chinese. Bone. 2006;38:584\u20138.","journal-title":"Bone"},{"key":"7102_CR21","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1007\/s10654-017-0285-4","volume":"32","author":"SK Kunutsor","year":"2017","unstructured":"Kunutsor SK, Blom AW, Whitehouse MR, Kehoe PG, Laukkanen JA. Renin-angiotensin system inhibitors and risk of fractures: a prospective cohort study and meta-analysis of published observational cohort studies. Eur J Epidemiol. 2017;32:947\u201359.","journal-title":"Eur J Epidemiol"},{"key":"7102_CR22","doi-asserted-by":"publisher","first-page":"e8331","DOI":"10.1097\/MD.0000000000008331","volume":"96","author":"CI Chen","year":"2017","unstructured":"Chen CI, Yeh JS, Tsao NW, Lin FY, Shih CM, Chiang KH, et al. Association between renin-angiotensin-aldosterone system blockade and future osteoporotic fracture risk in hypertensive population: a population-based cohort study in Taiwan. Medicine (Baltimore). 2017;96:e8331.","journal-title":"Medicine (Baltimore)"},{"key":"7102_CR23","doi-asserted-by":"publisher","first-page":"e0122691","DOI":"10.1371\/journal.pone.0122691","volume":"10","author":"S Yamamoto","year":"2015","unstructured":"Yamamoto S, Kido R, Onishi Y, Fukuma S, Akizawa T, Fukagawa M, et al. Use of renin-angiotensin system inhibitors is associated with reduction of fracture risk in hemodialysis patients. PLoS One. 2015;10:e0122691.","journal-title":"PLoS One"},{"key":"7102_CR24","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1677\/joe.0.1520005","volume":"152","author":"R Hatton","year":"1997","unstructured":"Hatton R, Stimpel M, Chambers TJ. Angiotensin II is generated from angiotensin I by bone cells and stimulates osteoclastic bone resorption in vitro. J Endocrinol. 1997;152:5\u201310.","journal-title":"J Endocrinol"},{"key":"7102_CR25","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/jbmr.3576","volume":"34","author":"PY Chang","year":"2019","unstructured":"Chang PY, Feldman D, Stefanick ML, McDonnell DP, Thompson BM, McDonald JG, et al. 27-Hydroxycholesterol, an endogenous SERM, and risk of fracture in postmenopausal women: a nested case-cohort study in the women\u2019s health initiative. J Bone Miner Res. 2019;34:59\u201366.","journal-title":"J Bone Miner Res"},{"key":"7102_CR26","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/S0008-6363(01)00479-5","volume":"53","author":"M Fischer","year":"2002","unstructured":"Fischer M, Baessler A, Schunkert H. Renin angiotensin system and gender differences in the cardiovascular system. Cardiovasc Res. 2002;53:672\u20137.","journal-title":"Cardiovasc Res"},{"key":"7102_CR27","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1046\/j.1523-1755.1999.00260.x","volume":"55","author":"JA Miller","year":"1999","unstructured":"Miller JA, Anacta LA, Cattran DC. Impact of gender on the renal response to angiotensin II. Kidney Int. 1999;55:278\u201385.","journal-title":"Kidney Int"},{"key":"7102_CR28","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1096\/fj.07-098954","volume":"22","author":"H Shimizu","year":"2008","unstructured":"Shimizu H, Nakagami H, Osako MK, Hanayama R, Kunugiza Y, Kizawa T, et al. Angiotensin II accelerates osteoporosis by activating osteoclasts. FASEB J. 2008;22:2465\u201375.","journal-title":"FASEB J"},{"key":"7102_CR29","first-page":"57","volume":"46","author":"T Kwok","year":"2017","unstructured":"Kwok T, Leung J, Barrett-Connor E, Osteoporotic Fractures in Men Research G. ARB users exhibit a lower fracture incidence than ACE inhibitor users among older hypertensive men. Age Ageing. 2017;46:57\u201364.","journal-title":"Age Ageing"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-023-07102-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12891-023-07102-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-023-07102-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T21:20:13Z","timestamp":1704230413000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-023-07102-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,2]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["7102"],"URL":"https:\/\/doi.org\/10.1186\/s12891-023-07102-5","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,2]]},"assertion":[{"value":"18 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study protocol was approved by the Ethics Committee of Pusan National University and the study was conducted in accordance with the principles of the Declaration of Helsinki. As the study is based on retrospective analyses of existing anonymous administrative and clinical data, the requirement for informed subject consent was waived by the Institutional Review Board of Pusan National University (PNU IRB\/2020_123_HR). Because this study is based on the retrospective analysis of existing administrative and clinical data, the requirement of obtaining informed patient consent was waived by the Institutional Review Board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3"}}